English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community
Press release submission | Jul 23, 2019

BAYER: Daily Aspirin Still Recommended for Millions of Americans Who Have Had a Heart Attack or Ischemic Stroke

Press release submission | Jul 19, 2019

BACKPACK HEALTH: Patients with Hereditary Hemorrhagic Telangiectasia (HHT) Gain Full Access to Critical Health Data Management Platform

Press release submission | Jul 18, 2019

AMERICAN RED CROSS: Red Cross Campaign Motivates Nearly 300,000 Blood Donors to Fill Missing Types for Patients in Need

Press release submission | Jul 13, 2019

ELI LILLY AND COMPANY: AHS 2019: Post-Hoc Analyses of Phase 3 Pivotal Studies of Emgality® (galcanezumab-gnlm) Show Improvements in Daily Functioning and Reductions in Disability in Patients with Chronic and Episodic Migraine

Press release submission | Jul 12, 2019

EIP PHARMA, INC.: Initiates New Study with Neflamapimod for the Treatment of Cognitive Deficits in Patients with Dementia with Lewy Bodies

Press release submission | Jul 2, 2019

BIOGEN, INC.: Announces New Data Further Establishing SPINRAZA® (nusinersen) as a Foundation of Care in Spinal Muscular Atrophy for a Broad Range of Patients

Press release submission | Jul 1, 2019

EXPERIMENTAL BIOLOGY AND MEDICINE: A New Target for the Treatment of Idiopathic Pulmonary Fibrosis

Press release submission | Jun 28, 2019

AJ VACCINES: Will Contribute to Global Polio Eradication With its Innovative Vaccine Picovax

Trending

+ Pharmaceuticals
Patient Daily | Jun 2, 2025

PathAI collaborates with Northwestern Medicine on digital pathology advancements

+ Pharmaceuticals
Patient Daily | May 29, 2025

Executive director of COA on 340B reform: ‘Start with PBMs then mega hospitals that pocket 340B discounts’

+ Regulatory
Patient Daily | May 30, 2025

Alliance for Pharmacy Compounding calls for eliminating redundant, unauthorized, or ineffective regulation

+ Pharmaceuticals
Patient Daily | May 28, 2025

University of California medical researcher: ‘The 340B program is not associated with an improvement in mortality for low-income patients'

  • « First
  • «
  • …
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2025 Patient Daily